Thursday, July 9, 2020

Japanese Startup Uses AI To Screen for COVID-19

Researchers are racing to discover the right drug molecule to treat COVID-19 — but the number of potential drug-like molecules out there is estimated to be an inconceivable 1060

“Even if you hypothetically checked one molecule per second, it would take longer than the age of the universe to explore the entire chemical space,” said Shinya Yuki, co-founder and CEO of Tokyo-based startup Elix, Inc.